 |
PDBsum entry 4zak
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4zak
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
267 a.a.
|
 |
|
|
|
|
|
|
|
98 a.a.
|
 |
|
|
|
|
|
|
|
203 a.a.
|
 |
|
|
|
|
|
|
|
239 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of the mcd1d/db06-1/inktcr ternary complex
|
|
Structure:
|
 |
Antigen-presenting glycoprotein cd1d1. Chain: a. Engineered: yes. Beta-2-microglobulin. Chain: b. Engineered: yes. Protein trav11,va14ja18/vb8.2,human nkt tcr alpha chain. Chain: c. Synonym: protein trav11d,human nkt tcr beta chain.
|
|
Source:
|
 |
Mus musculus. Mouse. Organism_taxid: 10090. Gene: cd1d1, cd1.1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: b2m. Mus musculus, homo sapiens. Mouse, human.
|
|
Resolution:
|
 |
|
2.82Å
|
R-factor:
|
0.218
|
R-free:
|
0.256
|
|
|
Authors:
|
 |
D.M.Zajonc,A.M.Birkholz
|
|
Key ref:
|
 |
A.M.Birkholz
et al.
(2015).
A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
J Immunol,
195,
924-933.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Apr-15
|
Release date:
|
01-Jul-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P11609
(CD1D1_MOUSE) -
Antigen-presenting glycoprotein CD1d1 from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
336 a.a.
267 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P01887
(B2MG_MOUSE) -
Beta-2-microglobulin from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
119 a.a.
98 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
A0A0B4J1J9
(A0A0B4J1J9_MOUSE) -
T cell receptor alpha variable 11 (Fragment) from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
114 a.a.
203 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
A0A0G2JG46
(A0A0G2JG46_MOUSE) -
T cell receptor alpha joining 18 (Fragment) from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
22 a.a.
203 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
K7N5M3
(K7N5M3_HUMAN) -
Human nkt tcr alpha chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
220 a.a.
203 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
A0A5B9
(TRBC2_HUMAN) -
T cell receptor beta constant 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
178 a.a.
239 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Immunol
195:924-933
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
|
|
A.M.Birkholz,
E.Girardi,
G.Wingender,
A.Khurana,
J.Wang,
M.Zhao,
S.Zahner,
P.A.Illarionov,
X.Wen,
M.Li,
W.Yuan,
S.A.Porcelli,
G.S.Besra,
D.M.Zajonc,
M.Kronenberg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In this article, we characterize a novel Ag for invariant NKT (iNKT) cells
capable of producing an especially robust Th1 response. This glycosphingolipid,
DB06-1, is similar in chemical structure to the well-studied
α-galactosylceramide (αGalCer), with the only change being a single atom: the
substitution of a carbonyl oxygen with a sulfur atom. Although DB06-1 is not a
more effective Ag in vitro, the small chemical change has a marked impact on the
ability of this lipid Ag to stimulate iNKT cells in vivo, with increased IFN-γ
production at 24 h compared with αGalCer, increased IL-12, and increased
activation of NK cells to produce IFN-γ. These changes are correlated with an
enhanced ability of DB06-1 to load in the CD1d molecules expressed by dendritic
cells in vivo. Moreover, structural studies suggest a tighter fit into the CD1d
binding groove by DB06-1 compared with αGalCer. Surprisingly, when iNKT cells
previously exposed to DB06-1 are restimulated weeks later, they have greatly
increased IL-10 production. Therefore, our data are consistent with a model
whereby augmented and or prolonged presentation of a glycolipid Ag leads to
increased activation of NK cells and a Th1-skewed immune response, which may
result, in part, from enhanced loading into CD1d. Furthermore, our data suggest
that strong antigenic stimulation in vivo may lead to the expansion of
IL-10-producing iNKT cells, which could counteract the benefits of increased
early IFN-γ production.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |